CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...

Strong Memorial Hospital is among a select few in the U.S. offering Carvykti, a treatment for multiple myeloma, a cancer in ...

Multiple myeloma causes an expression of too much protein in a way that leads to excessive bone breakdown that isn’t properly balanced by new bone growth. How do multiple myeloma bone lesions feel?

Although multiple myeloma currently remains an incurable disease, ongoing research and innovation offer hope for improving survival rates and quality of life. 1 We are getting closer to potential ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Multiple Myeloma (MM), a chronic and currently incurable hematologic malignancy, remains one of the most dynamic and competitive therapeutic landscapes in oncology. Originating from abnormal plasma ...

Beerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products ...

The future of multiple myeloma treatment is personalised, but collaboration is essential to deliver it. Learn about the latest advancements and how working together can improve outcomes for patients.

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...